These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36129964)

  • 41. vaRHC: an R package for semi-automation of variant classification in hereditary cancer genes according to ACMG/AMP and gene-specific ClinGen guidelines.
    Munté E; Feliubadaló L; Pineda M; Tornero E; Gonzalez M; Moreno-Cabrera JM; Roca C; Bales Rubio J; Arnaldo L; Capellá G; Mosquera JL; Lázaro C
    Bioinformatics; 2023 Mar; 39(3):. PubMed ID: 36916756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative analysis of functional assay evidence use by ClinGen Variant Curation Expert Panels.
    Kanavy DM; McNulty SM; Jairath MK; Brnich SE; Bizon C; Powell BC; Berg JS
    Genome Med; 2019 Nov; 11(1):77. PubMed ID: 31783775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Challenges and approaches to calibrating patient phenotype as evidence for cancer gene variant classification under ACMG/AMP guidelines.
    Fortuno C; Michailidou K; Parsons M; Dolinsky JS; Pesaran T; Yussuf A; Mester JL; Hruska KS; Hiraki S; O'Connor R; Chan RC; Kim S; Tavtigian SV; Goldgar D; James PA; Spurdle AB
    Hum Mol Genet; 2024 Apr; 33(8):724-732. PubMed ID: 38271184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The hospital Israelita Albert Einstein standards for constitutional sequence variants classification: version 2023.
    Quaio CRDC; Ceroni JRM; Pereira MA; Teixeira ACB; Yamada RY; Cintra VP; Perrone E; De França M; Chen K; Minillo RM; Biondo CA; de Mello MRB; Moura LR; do Nascimento ATB; de Oliveira Pelegrino K; de Lima LB; do Amaral Virmond L; Moreno CA; Prota JRM; de Araujo Espolaor JG; Silva TYT; Moraes GHI; de Oliveira GS; Moura LMS; Caraciolo MP; Guedes RLM; Gretschischkin MC; Chazanas PLN; Nakamura CNI; de Souza Reis R; Toledo CM; Lage FSD; de Almeida GB; do Nascimento Júnior JB; Cardoso MA; de Paula Azevedo V; de Almeida TF; Cervato MC; de Oliveira Filho JB
    Hum Genomics; 2023 Nov; 17(1):102. PubMed ID: 37968704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cruxome: a powerful tool for annotating, interpreting and reporting genetic variants.
    Han Q; Yang Y; Wu S; Liao Y; Zhang S; Liang H; Cram DS; Zhang Y
    BMC Genomics; 2021 Jun; 22(1):407. PubMed ID: 34082700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unique aspects of sequence variant interpretation for inborn errors of metabolism (IEM): The ClinGen IEM Working Group and the Phenylalanine Hydroxylase Gene.
    Zastrow DB; Baudet H; Shen W; Thomas A; Si Y; Weaver MA; Lager AM; Liu J; Mangels R; Dwight SS; Wright MW; Dobrowolski SF; Eilbeck K; Enns GM; Feigenbaum A; Lichter-Konecki U; Lyon E; Pasquali M; Watson M; Blau N; Steiner RD; Craigen WJ; Mao R;
    Hum Mutat; 2018 Nov; 39(11):1569-1580. PubMed ID: 30311390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantifying the potential of functional evidence to reclassify variants of uncertain significance in the categorical and Bayesian interpretation frameworks.
    Brnich SE; Rivera-Muñoz EA; Berg JS
    Hum Mutat; 2018 Nov; 39(11):1531-1541. PubMed ID: 30095857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improving genetic diagnosis by disease-specific, ACMG/AMP variant interpretation guidelines for hearing loss.
    Kim SY; Kim BJ; Oh DY; Han JH; Yi N; Kim NJ; Park MK; Keum C; Seo GH; Choi BY
    Sci Rep; 2022 Jul; 12(1):12457. PubMed ID: 35864128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer SIGVAR: A semiautomated interpretation tool for germline variants of hereditary cancer-related genes.
    Li H; Liu S; Wang S; Zeng Q; Chen Y; Fang T; Zhang Y; Zhou Y; Zhang Y; Wang K; Yan Z; Qiang C; Xu M; Chai X; Yuan Y; Huang M; Zhang H; Xiong Y
    Hum Mutat; 2021 Apr; 42(4):359-372. PubMed ID: 33565189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants.
    He MM; Li Q; Yan M; Cao H; Hu Y; He KY; Cao K; Li MM; Wang K
    Genome Med; 2019 Aug; 11(1):53. PubMed ID: 31443733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determination of Pathogenicity of
    Brown A; Zamanpoor M; Love DR; Prosser DO
    Sultan Qaboos Univ Med J; 2019 Nov; 19(4):e324-e334. PubMed ID: 31897316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variant Selection and Interpretation: An Example of Modified VarSome Classifier of ACMG Guidelines in the Diagnostic Setting.
    Cristofoli F; Sorrentino E; Guerri G; Miotto R; Romanelli R; Zulian A; Cecchin S; Paolacci S; Miertus J; Bertelli M; Maltese PE; Chiurazzi P; Stuppia L; Castori M; Marceddu G
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toward automation of germline variant curation in clinical cancer genetics.
    Ravichandran V; Shameer Z; Kemel Y; Walsh M; Cadoo K; Lipkin S; Mandelker D; Zhang L; Stadler Z; Robson M; Offit K; Vijai J
    Genet Med; 2019 Sep; 21(9):2116-2125. PubMed ID: 30787465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The current state of clinical interpretation of sequence variants.
    Hoskinson DC; Dubuc AM; Mason-Suares H
    Curr Opin Genet Dev; 2017 Feb; 42():33-39. PubMed ID: 28157586
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes.
    Walsh MF; Ritter DI; Kesserwan C; Sonkin D; Chakravarty D; Chao E; Ghosh R; Kemel Y; Wu G; Lee K; Kulkarni S; Hedges D; Mandelker D; Ceyhan-Birsoy O; Luo M; Drazer M; Zhang L; Offit K; Plon SE
    Hum Mutat; 2018 Nov; 39(11):1542-1552. PubMed ID: 30311369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Updated recommendation for the benign stand-alone ACMG/AMP criterion.
    Ghosh R; Harrison SM; Rehm HL; Plon SE; Biesecker LG;
    Hum Mutat; 2018 Nov; 39(11):1525-1530. PubMed ID: 30311383
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines.
    Tavtigian SV; Harrison SM; Boucher KM; Biesecker LG
    Hum Mutat; 2020 Oct; 41(10):1734-1737. PubMed ID: 32720330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Consideration of Cosegregation in the Pathogenicity Classification of Genomic Variants.
    Jarvik GP; Browning BL
    Am J Hum Genet; 2016 Jun; 98(6):1077-1081. PubMed ID: 27236918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical impact of re-evaluating genes and variants implicated in dilated cardiomyopathy.
    Stroeks SLVM; Hellebrekers DMEI; Claes GRF; Tayal U; Krapels IPC; Vanhoutte EK; van den Wijngaard A; Henkens MTHM; Ware JS; Heymans SRB; Brunner HG; Verdonschot JAJ
    Genet Med; 2021 Nov; 23(11):2186-2193. PubMed ID: 34194005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of ACMG criteria to classify variants in the human gene mutation database.
    Qu HQ; Wang X; Tian L; Hakonarson H
    J Hum Genet; 2019 Nov; 64(11):1091-1095. PubMed ID: 31451714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.